Methodologies for Anti-HLA antibody screening in patients awaiting kidney transplant

A comparative study

Pellegrino B. Minucci, Vincenzo Grimaldi, Amelia Casamassimi, Francesco Cacciatore, Linda Sommese, Antonietta Picascia, Marianna Resse, Chiara Sabia, Adolfo Russo, Claudio Napoli

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objectives: The relevance of anti-HLA antibodies in patients awaiting kidney transplants is well recognized. During the past 40 years, kidney transplant candidates have been tested for these antibodies, and the choice of the detection assay has become essential. Recently, the pioneer method, the complement-dependent cytotoxicity, has been integrated but has not been replaced by more-sensitive solid-phase assays, such as the enzyme-linked immunosorbent assay and the bead-based technology (ie, flow cytometry: FlowPRA, and FlowAnalyzer: Luminex). Materials and Methods: We compared the sensitivity and antibody specificity of these 4 techniques for detecting panel-reactive antibodies in a population of 101 consecutive patients awaiting a renal transplant (which had already resulted positive in a prescreening analysis).Results: Sera positive for class I and class II antibodies were 62 and 90 as assessed by the complement-dependent cytotoxicity method, 76 and 58 by using enzyme-linked immunosorbent assay, 83 and 65 with Flow-panel-reactive antibodies, and 90 and 79 by Luminex. Luminex gave more positive scores than the others for class I HLA antibodies, whereas complement-dependent cytotoxicity revealed more positives for those of class II.Conclusions: Although Luminex appears more efficient among these assays, our results indicate that use of multiple methods is still the best approach for characterizing the immunologic status of these patients.

Original languageEnglish
Pages (from-to)381-386
Number of pages6
JournalExperimental and Clinical Transplantation
Volume9
Issue number6
Publication statusPublished - Dec 2011

Fingerprint

Anti-Idiotypic Antibodies
Transplants
Kidney
Antibodies
Enzyme-Linked Immunosorbent Assay
Antibody Specificity
Immunoglobulin Isotypes
Flow Cytometry
Technology
Sensitivity and Specificity
Serum
Population

Keywords

  • CDC
  • ELISA
  • Flow-PRA
  • HLA antibody. class I and class II antibodies
  • Luminex

ASJC Scopus subject areas

  • Transplantation

Cite this

Methodologies for Anti-HLA antibody screening in patients awaiting kidney transplant : A comparative study. / Minucci, Pellegrino B.; Grimaldi, Vincenzo; Casamassimi, Amelia; Cacciatore, Francesco; Sommese, Linda; Picascia, Antonietta; Resse, Marianna; Sabia, Chiara; Russo, Adolfo; Napoli, Claudio.

In: Experimental and Clinical Transplantation, Vol. 9, No. 6, 12.2011, p. 381-386.

Research output: Contribution to journalArticle

Minucci, PB, Grimaldi, V, Casamassimi, A, Cacciatore, F, Sommese, L, Picascia, A, Resse, M, Sabia, C, Russo, A & Napoli, C 2011, 'Methodologies for Anti-HLA antibody screening in patients awaiting kidney transplant: A comparative study', Experimental and Clinical Transplantation, vol. 9, no. 6, pp. 381-386.
Minucci, Pellegrino B. ; Grimaldi, Vincenzo ; Casamassimi, Amelia ; Cacciatore, Francesco ; Sommese, Linda ; Picascia, Antonietta ; Resse, Marianna ; Sabia, Chiara ; Russo, Adolfo ; Napoli, Claudio. / Methodologies for Anti-HLA antibody screening in patients awaiting kidney transplant : A comparative study. In: Experimental and Clinical Transplantation. 2011 ; Vol. 9, No. 6. pp. 381-386.
@article{8eb2e141c725475384ef2bac2bfed810,
title = "Methodologies for Anti-HLA antibody screening in patients awaiting kidney transplant: A comparative study",
abstract = "Objectives: The relevance of anti-HLA antibodies in patients awaiting kidney transplants is well recognized. During the past 40 years, kidney transplant candidates have been tested for these antibodies, and the choice of the detection assay has become essential. Recently, the pioneer method, the complement-dependent cytotoxicity, has been integrated but has not been replaced by more-sensitive solid-phase assays, such as the enzyme-linked immunosorbent assay and the bead-based technology (ie, flow cytometry: FlowPRA, and FlowAnalyzer: Luminex). Materials and Methods: We compared the sensitivity and antibody specificity of these 4 techniques for detecting panel-reactive antibodies in a population of 101 consecutive patients awaiting a renal transplant (which had already resulted positive in a prescreening analysis).Results: Sera positive for class I and class II antibodies were 62 and 90 as assessed by the complement-dependent cytotoxicity method, 76 and 58 by using enzyme-linked immunosorbent assay, 83 and 65 with Flow-panel-reactive antibodies, and 90 and 79 by Luminex. Luminex gave more positive scores than the others for class I HLA antibodies, whereas complement-dependent cytotoxicity revealed more positives for those of class II.Conclusions: Although Luminex appears more efficient among these assays, our results indicate that use of multiple methods is still the best approach for characterizing the immunologic status of these patients.",
keywords = "CDC, ELISA, Flow-PRA, HLA antibody. class I and class II antibodies, Luminex",
author = "Minucci, {Pellegrino B.} and Vincenzo Grimaldi and Amelia Casamassimi and Francesco Cacciatore and Linda Sommese and Antonietta Picascia and Marianna Resse and Chiara Sabia and Adolfo Russo and Claudio Napoli",
year = "2011",
month = "12",
language = "English",
volume = "9",
pages = "381--386",
journal = "Current Alzheimer Research",
issn = "1567-2050",
publisher = "Bentham Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - Methodologies for Anti-HLA antibody screening in patients awaiting kidney transplant

T2 - A comparative study

AU - Minucci, Pellegrino B.

AU - Grimaldi, Vincenzo

AU - Casamassimi, Amelia

AU - Cacciatore, Francesco

AU - Sommese, Linda

AU - Picascia, Antonietta

AU - Resse, Marianna

AU - Sabia, Chiara

AU - Russo, Adolfo

AU - Napoli, Claudio

PY - 2011/12

Y1 - 2011/12

N2 - Objectives: The relevance of anti-HLA antibodies in patients awaiting kidney transplants is well recognized. During the past 40 years, kidney transplant candidates have been tested for these antibodies, and the choice of the detection assay has become essential. Recently, the pioneer method, the complement-dependent cytotoxicity, has been integrated but has not been replaced by more-sensitive solid-phase assays, such as the enzyme-linked immunosorbent assay and the bead-based technology (ie, flow cytometry: FlowPRA, and FlowAnalyzer: Luminex). Materials and Methods: We compared the sensitivity and antibody specificity of these 4 techniques for detecting panel-reactive antibodies in a population of 101 consecutive patients awaiting a renal transplant (which had already resulted positive in a prescreening analysis).Results: Sera positive for class I and class II antibodies were 62 and 90 as assessed by the complement-dependent cytotoxicity method, 76 and 58 by using enzyme-linked immunosorbent assay, 83 and 65 with Flow-panel-reactive antibodies, and 90 and 79 by Luminex. Luminex gave more positive scores than the others for class I HLA antibodies, whereas complement-dependent cytotoxicity revealed more positives for those of class II.Conclusions: Although Luminex appears more efficient among these assays, our results indicate that use of multiple methods is still the best approach for characterizing the immunologic status of these patients.

AB - Objectives: The relevance of anti-HLA antibodies in patients awaiting kidney transplants is well recognized. During the past 40 years, kidney transplant candidates have been tested for these antibodies, and the choice of the detection assay has become essential. Recently, the pioneer method, the complement-dependent cytotoxicity, has been integrated but has not been replaced by more-sensitive solid-phase assays, such as the enzyme-linked immunosorbent assay and the bead-based technology (ie, flow cytometry: FlowPRA, and FlowAnalyzer: Luminex). Materials and Methods: We compared the sensitivity and antibody specificity of these 4 techniques for detecting panel-reactive antibodies in a population of 101 consecutive patients awaiting a renal transplant (which had already resulted positive in a prescreening analysis).Results: Sera positive for class I and class II antibodies were 62 and 90 as assessed by the complement-dependent cytotoxicity method, 76 and 58 by using enzyme-linked immunosorbent assay, 83 and 65 with Flow-panel-reactive antibodies, and 90 and 79 by Luminex. Luminex gave more positive scores than the others for class I HLA antibodies, whereas complement-dependent cytotoxicity revealed more positives for those of class II.Conclusions: Although Luminex appears more efficient among these assays, our results indicate that use of multiple methods is still the best approach for characterizing the immunologic status of these patients.

KW - CDC

KW - ELISA

KW - Flow-PRA

KW - HLA antibody. class I and class II antibodies

KW - Luminex

UR - http://www.scopus.com/inward/record.url?scp=83455242890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83455242890&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 381

EP - 386

JO - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1567-2050

IS - 6

ER -